Tag: FDA biosimilars
FDA Listing for Biosimilars: How They Are Evaluated and Approved
Posted by Michael Sumner in Pharmaceuticals
22Mar
The FDA doesn't rate biosimilars like generics - it uses a rigorous science-based process to approve them. Learn how biosimilars are evaluated, listed in the Purple Book, and why they're not interchangeable by default.
More